1. Home
  2. RPRX vs THC Comparison

RPRX vs THC Comparison

Compare RPRX & THC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • THC
  • Stock Information
  • Founded
  • RPRX 1996
  • THC 1967
  • Country
  • RPRX United States
  • THC United States
  • Employees
  • RPRX N/A
  • THC N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • THC Hospital/Nursing Management
  • Sector
  • RPRX Health Care
  • THC Health Care
  • Exchange
  • RPRX Nasdaq
  • THC Nasdaq
  • Market Cap
  • RPRX 14.2B
  • THC 11.7B
  • IPO Year
  • RPRX 2020
  • THC N/A
  • Fundamental
  • Price
  • RPRX $32.20
  • THC $122.06
  • Analyst Decision
  • RPRX Strong Buy
  • THC Buy
  • Analyst Count
  • RPRX 4
  • THC 18
  • Target Price
  • RPRX $42.50
  • THC $165.11
  • AVG Volume (30 Days)
  • RPRX 4.5M
  • THC 1.5M
  • Earning Date
  • RPRX 05-08-2025
  • THC 04-29-2025
  • Dividend Yield
  • RPRX 2.73%
  • THC N/A
  • EPS Growth
  • RPRX N/A
  • THC 473.12
  • EPS
  • RPRX 1.91
  • THC 32.70
  • Revenue
  • RPRX $2,263,576,000.00
  • THC $20,665,000,000.00
  • Revenue This Year
  • RPRX $31.56
  • THC $2.10
  • Revenue Next Year
  • RPRX $5.94
  • THC $5.08
  • P/E Ratio
  • RPRX $16.84
  • THC $3.73
  • Revenue Growth
  • RPRX N/A
  • THC 0.57
  • 52 Week Low
  • RPRX $24.05
  • THC $92.01
  • 52 Week High
  • RPRX $34.20
  • THC $171.20
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 51.13
  • THC 47.74
  • Support Level
  • RPRX $31.58
  • THC $109.82
  • Resistance Level
  • RPRX $32.73
  • THC $124.62
  • Average True Range (ATR)
  • RPRX 0.93
  • THC 6.88
  • MACD
  • RPRX 0.06
  • THC -0.11
  • Stochastic Oscillator
  • RPRX 82.74
  • THC 52.74

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About THC Tenet Healthcare Corporation

Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of December 2023) and over 450 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Share on Social Networks: